Zheng, Xiao-Feng
Acharya, Sanket S.
Choe, Katherine N.
Nikhil, Kumar
Adelmant, Guillaume http://orcid.org/0000-0003-4075-5486
Satapathy, Shakti Ranjan
Sharma, Samanta
Viccaro, Keith
Rana, Sandeep
Natarajan, Amarnath http://orcid.org/0000-0001-5067-0203
Sicinski, Peter http://orcid.org/0000-0002-8859-5234
Marto, Jarrod A. http://orcid.org/0000-0003-2086-1134
Shah, Kavita http://orcid.org/0000-0002-0451-1305
Chowdhury, Dipanjan http://orcid.org/0000-0001-5645-3752
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA208244)
Leukemia and Lymphoma Society
Article History
Received: 18 March 2019
Accepted: 20 August 2019
First Online: 18 September 2019
Competing interests
: J.A.M. serves on the Scientific Advisory Board of 908 Devices. P.S. has been a consultant at Novartis, Genovis, Guidepoint, The Planning Shop, ORIC Pharmaceuticals and Exo Therapeutics; his laboratory receives research funding from Novartis. The remaining authors declare no competing interests.